Washington: Researchers have identified 14 new biomarkers for type 2 diabetes, which can serve as basis for developing new methods of treatment and prevention of this metabolic disease.The biomarkers can also be used to determine diabetes risk at a very early point in time. At the same time the markers enable insight into the complex mechanisms of this disease, which still have not been completely elucidated.The researchers led by Anna Floegel of the German Institute of Human Nutrition (DIfE) and Tobias Pischon of the Max Delbrueck Center studied the blood of study participants from three different studies with respect to their metabolites (metabolomics).The study was based on data and blood samples of the prospective EPIC-Potsdam study with more than 27,500 study participants, the Tuebingen family study and the KORA study. The study was conducted in collaboration with the German Center for Diabetes Research (DZD) and funded by the Federal Ministry of Education and Research (BMBF). The aim of the current study was to identify metabolites in blood, which provide insight into the pathomechanisms of type 2 diabetes and in addition can be used as biomarkers to determine the disease risk.
UN posting gives Devyani temporary immunity: US
Petrol, Diesel and milk prices hiked in Mumbai
`Dhoom 3` audience verdict
Lieutenant Governor Najeeb Jung recommends President`s rule in Delhi